193 related articles for article (PubMed ID: 31325765)
1. Monoclonal Antibodies Against Human Papillomavirus E6 and E7 Oncoproteins Inhibit Tumor Growth in Experimental Cervical Cancer.
Jiang Z; Albanese J; Kesterson J; Warrick J; Karabakhtsian R; Dadachova E; Phaëton R
Transl Oncol; 2019 Oct; 12(10):1289-1295. PubMed ID: 31325765
[TBL] [Abstract][Full Text] [Related]
2. Radiation-enhanced expression of E6/E7 transforming oncogenes of human papillomavirus-16 in human cervical carcinoma.
Santin AD; Hermonat PL; Ravaggi A; Chiriva-Internati M; Pecorelli S; Parham GP
Cancer; 1998 Dec; 83(11):2346-52. PubMed ID: 9840534
[TBL] [Abstract][Full Text] [Related]
3. In vitro and in vivo growth inhibition of human cervical cancer cells via human papillomavirus E6/E7 mRNAs' cleavage by CRISPR/Cas13a system.
Chen Y; Jiang H; Wang T; He D; Tian R; Cui Z; Tian X; Gao Q; Ma X; Yang J; Wu J; Tan S; Xu H; Tang X; Wang Y; Yu Z; Han H; Das BC; Severinov K; Hitzeroth II; Debata PR; Xu W; Fan W; Jin Z; Cao C; Yu M; Xie W; Huang Z; Hu Z; You Z
Antiviral Res; 2020 Jun; 178():104794. PubMed ID: 32298665
[TBL] [Abstract][Full Text] [Related]
4. Development of DNA Vaccine Targeting E6 and E7 Proteins of Human Papillomavirus 16 (HPV16) and HPV18 for Immunotherapy in Combination with Recombinant Vaccinia Boost and PD-1 Antibody.
Peng S; Ferrall L; Gaillard S; Wang C; Chi WY; Huang CH; Roden RBS; Wu TC; Chang YN; Hung CF
mBio; 2021 Jan; 12(1):. PubMed ID: 33468698
[TBL] [Abstract][Full Text] [Related]
5. Radioimmunotherapy with an antibody to the HPV16 E6 oncoprotein is effective in an experimental cervical tumor expressing low levels of E6.
Phaeton R; Harris M; Jiang Z; Wang XG; Einstein MH; Goldberg GL; Casadevall A; Dadachova E
Cancer Biol Ther; 2010 Nov; 10(10):1041-7. PubMed ID: 20861673
[TBL] [Abstract][Full Text] [Related]
6. In vitro antigene therapy targeting HPV-16 E6 and E7 in cervical carcinoma.
Madrigal M; Janicek MF; Sevin BU; Perras J; Estape R; Peñalver M; Averette HE
Gynecol Oncol; 1997 Jan; 64(1):18-25. PubMed ID: 8995542
[TBL] [Abstract][Full Text] [Related]
7. Beta emitters rhenium-188 and lutetium-177 are equally effective in radioimmunotherapy of HPV-positive experimental cervical cancer.
Phaeton R; Jiang Z; Revskaya E; Fisher DR; Goldberg GL; Dadachova E
Cancer Med; 2016 Jan; 5(1):9-16. PubMed ID: 26625938
[TBL] [Abstract][Full Text] [Related]
8. Intrabodies targeting human papillomavirus 16 E6 and E7 oncoproteins for therapy of established HPV-associated tumors.
Paolini F; Amici C; Carosi M; Bonomo C; Di Bonito P; Venuti A; Accardi L
J Exp Clin Cancer Res; 2021 Jan; 40(1):37. PubMed ID: 33485370
[TBL] [Abstract][Full Text] [Related]
9. Relationship between vaginal microecological changes and oncogene E6/E7 and high-risk human papillomavirus infection.
Huang J; Yin C; Wang J
J Obstet Gynaecol; 2023 Dec; 43(1):2161349. PubMed ID: 36645341
[TBL] [Abstract][Full Text] [Related]
10. Bacterial Species from Vaginal Microbiota Differently Affect the Production of the E6 and E7 Oncoproteins and of p53 and p-Rb Oncosuppressors in HPV16-Infected Cells.
Nicolò S; Antonelli A; Tanturli M; Baccani I; Bonaiuto C; Castronovo G; Rossolini GM; Mattiuz G; Torcia MG
Int J Mol Sci; 2023 Apr; 24(8):. PubMed ID: 37108333
[TBL] [Abstract][Full Text] [Related]
11. Silencing of HPV 18 oncoproteins With RNA interference causes growth inhibition of cervical cancer cells.
Lea JS; Sunaga N; Sato M; Kalahasti G; Miller DS; Minna JD; Muller CY
Reprod Sci; 2007 Jan; 14(1):20-8. PubMed ID: 17636212
[TBL] [Abstract][Full Text] [Related]
12. Inactivation of the human papillomavirus E6 or E7 gene in cervical carcinoma cells by using a bacterial CRISPR/Cas RNA-guided endonuclease.
Kennedy EM; Kornepati AV; Goldstein M; Bogerd HP; Poling BC; Whisnant AW; Kastan MB; Cullen BR
J Virol; 2014 Oct; 88(20):11965-72. PubMed ID: 25100830
[TBL] [Abstract][Full Text] [Related]
13. Systemic delivery of siRNA by actively targeted polyion complex micelles for silencing the E6 and E7 human papillomavirus oncogenes.
Nishida H; Matsumoto Y; Kawana K; Christie RJ; Naito M; Kim BS; Toh K; Min HS; Yi Y; Matsumoto Y; Kim HJ; Miyata K; Taguchi A; Tomio K; Yamashita A; Inoue T; Nakamura H; Fujimoto A; Sato M; Yoshida M; Adachi K; Arimoto T; Wada-Hiraike O; Oda K; Nagamatsu T; Nishiyama N; Kataoka K; Osuga Y; Fujii T
J Control Release; 2016 Jun; 231():29-37. PubMed ID: 26979870
[TBL] [Abstract][Full Text] [Related]
14. Antisense targeting human papillomavirus type 16 E6 and E7 genes contributes to apoptosis and senescence in SiHa cervical carcinoma cells.
Sima N; Wang S; Wang W; Kong D; Xu Q; Tian X; Luo A; Zhou J; Xu G; Meng L; Lu Y; Ma D
Gynecol Oncol; 2007 Aug; 106(2):299-304. PubMed ID: 17586029
[TBL] [Abstract][Full Text] [Related]
15. Immunohistochemical Evaluation of E6/E7 HPV Oncoproteins Staining in Cervical Cancer.
Stiasny A; Kuhn C; Mayr D; Alexiou C; Janko C; Wiest I; Jeschke U; Kost B
Anticancer Res; 2016 Jun; 36(6):3195-8. PubMed ID: 27272848
[TBL] [Abstract][Full Text] [Related]
16. 3-(2-Chloropropyl amide)-4-methoxy-N-phenylbenzamide inhibits expression of HPV oncogenes in human cervical cancer cell.
Han F; Li Y; Lu Q; Ma L; Wang H; Jiang J; Li Z; Li Y
Virol J; 2017 Jul; 14(1):145. PubMed ID: 28754129
[TBL] [Abstract][Full Text] [Related]
17. Radioimmunotherapy of experimental head and neck squamous cell carcinoma (HNSCC) with E6-specific antibody using a novel HPV-16 positive HNSCC cell line.
Harris M; Wang XG; Jiang Z; Goldberg GL; Casadevall A; Dadachova E
Head Neck Oncol; 2011 Feb; 3(1):9. PubMed ID: 21314983
[TBL] [Abstract][Full Text] [Related]
18. Overexpression of human papillomavirus type 16 oncoproteins enhances hypoxia-inducible factor 1 alpha protein accumulation and vascular endothelial growth factor expression in human cervical carcinoma cells.
Tang X; Zhang Q; Nishitani J; Brown J; Shi S; Le AD
Clin Cancer Res; 2007 May; 13(9):2568-76. PubMed ID: 17473185
[TBL] [Abstract][Full Text] [Related]
19. Bioinformatics analysis of HPV-68 E6 and E7 oncoproteins for designing a therapeutic epitope vaccine against HPV infection.
Dong D; Zhu Y; Aili Z; Chen Z; Ding J
Infect Genet Evol; 2020 Jul; 81():104266. PubMed ID: 32114254
[TBL] [Abstract][Full Text] [Related]
20. TALEN-mediated targeting of HPV oncogenes ameliorates HPV-related cervical malignancy.
Hu Z; Ding W; Zhu D; Yu L; Jiang X; Wang X; Zhang C; Wang L; Ji T; Liu D; He D; Xia X; Zhu T; Wei J; Wu P; Wang C; Xi L; Gao Q; Chen G; Liu R; Li K; Li S; Wang S; Zhou J; Ma D; Wang H
J Clin Invest; 2015 Jan; 125(1):425-36. PubMed ID: 25500889
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
